Charles Schwab Investment Management Inc Tyra Biosciences, Inc. Transaction History

Charles Schwab Investment Management Inc

$557 Billion
Q2 2025

A detailed history of Charles Schwab Investment Management Inc transactions in Tyra Biosciences, Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 178,104 shares of TYRA stock, worth $2.65 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

178,104

Previous 164,108 8.53%

Holding current value

$2.65 Million

Previous $1.53 Million 11.66%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 12, 2025	BUY	$7.06 - $10.86 $98,811 - $151,996	13,996 Added 8.53%	178,104 $1.7 Million
Q1 2025 Sep 15, 2025	SELL	$9.3 - $16.73 $130,162 - $234,153	-13,996 Reduced 7.86%	164,108 $1.53 Million
Q1 2025 May 09, 2025	SELL	$9.3 - $16.73 $60,375 - $108,611	-6,492 Reduced 3.81%	164,108 $1.53 Million
Q4 2024 Feb 06, 2025	SELL	$13.9 - $28.61 $43,604 - $89,749	-3,137 Reduced 1.81%	170,600 $2.37 Million
Q3 2024 Nov 12, 2024	BUY	$16.7 - $24.36 $63,326 - $92,373	3,792 Added 2.23%	173,737 $4.08 Million
Q2 2024 Aug 12, 2024	BUY	$14.45 - $20.22 $256,241 - $358,561	17,733 Added 11.65%	169,945 $2.72 Million
Q1 2024 May 08, 2024	BUY	$11.61 - $20.0 $483,846 - $833,500	41,675 Added 37.7%	152,212 $2.5 Million
Q4 2023 Feb 06, 2024	BUY	$11.01 - $14.95 $3,556 - $4,828	323 Added 0.29%	110,537 $1.53 Million
Q3 2023 Nov 08, 2023	BUY	$13.15 - $16.08 $73,074 - $89,356	5,557 Added 5.31%	110,214 $1.52 Million
Q2 2023 Aug 09, 2023	BUY	$11.99 - $17.51 $27,421 - $40,045	2,287 Added 2.23%	104,657 $1.78 Million
Q1 2023 May 11, 2023	BUY	$6.85 - $16.22 $26,488 - $62,722	3,867 Added 3.93%	102,370 $1.65 Million
Q4 2022 Feb 13, 2023	BUY	$5.68 - $8.81 $13,223 - $20,509	2,328 Added 2.42%	98,503 $748,000
Q3 2022 Nov 14, 2022	BUY	$6.61 - $12.42 $98,317 - $184,735	14,874 Added 18.29%	96,175 $846,000
Q2 2022 Aug 15, 2022	BUY	$5.26 - $11.19 $4,444 - $9,455	845 Added 1.05%	81,301 $582,000
Q1 2022 May 13, 2022	BUY	$10.03 - $14.09 $11,123 - $15,625	1,109 Added 1.4%	80,456 $861,000
Q4 2021 Feb 11, 2022	BUY	$12.23 - $31.35 $970,413 - $2.49 Million	79,347 New	79,347 $1.12 Million

Others Institutions Holding TYRA

# of Institutions

123

Shares Held

59.9M

Call Options Held

Put Options Held

View Full List

About Tyra Biosciences, Inc.

Ticker TYRA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,973,600
Market Cap $625M
Description
Tyra Biosciences, Inc., a preclinical-stage biopharmaceutical company, focuses on developing therapies to overcome tumor resistance and enhance outcomes for patients with cancer. Its lead product candidate is TYRA-300, a selective inhibitor of fibroblast growth factor receptor (FGFR)3 for the treatment of muscle invasive bladder cancer. The comp...

More about TYRA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Charles Schwab Investment Management Inc with notifications on news.

Account

Charles Schwab Investment Management Inc Tyra Biosciences, Inc. Transaction History